The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss on extinguishment or repurchase of debt | - | 0 | 0 | -300 |
| Gains on lease modifications | - | 0 | 0 | 100 |
| Net loss | -17,100 | -7,600 | -9,600 | -46,800 |
| Step-up of equity method investments and unrealized gains on marketable securities | - | - | - | 4,900 |
| Share-based compensation expense | 600 | 500 | 700 | 1,500 |
| Depreciation and amortization (including amounts in cost of revenue) | 7,400 | 7,600 | 7,500 | 15,300 |
| Amortization of deferred financing costs and debt discount | 6,100 | 6,000 | 5,800 | 11,900 |
| Loss from equity investees | 0 | 0 | 0 | -5,900 |
| Gains on investments | 0 | 0 | 5,200 | - |
| Asset impairment expense | - | 0 | - | - |
| Deferred income tax expense | 0 | 0 | -200 | 100 |
| Other operating activities, net | 0 | -200 | 100 | -1,700 |
| Accounts receivable | -55,000 | -24,000 | 23,000 | 49,700 |
| Contract assets | -9,600 | -16,700 | -2,200 | -23,300 |
| Other current assets | -3,200 | 2,300 | 2,000 | -1,400 |
| Inventory | -600 | -2,100 | -2,600 | -100 |
| Other assets | -7,000 | -3,400 | -3,400 | -5,500 |
| Accounts payable | -14,200 | 42,500 | 19,700 | -5,100 |
| Accrued liabilities | 6,000 | 15,300 | 13,000 | 9,300 |
| Contract liabilities | -14,600 | -3,600 | 2,700 | 63,700 |
| Other current liabilities | 900 | 0 | -200 | -100 |
| Other liabilities | -5,000 | -3,700 | -3,000 | -7,000 |
| Cash provided by (used in) operating activities | 45,500 | 101,100 | 19,200 | 26,300 |
| Purchase of property, plant and equipment | 9,500 | 7,500 | 7,800 | 10,800 |
| Loans to equity method investee | - | 0 | 0 | 0 |
| Proceeds from disposal of property, plant and equipment | 100 | 0 | 200 | 1,200 |
| Purchase of investments | 0 | 0 | 0 | 300 |
| Proceeds from sale of investments | - | 0 | 2,900 | - |
| Cash paid for asset acquisitions | 200 | 0 | 200 | 300 |
| Other investing activities | - | 0 | 0 | 0 |
| Cash used in investing activities | -9,600 | -7,500 | -4,900 | -10,200 |
| Proceeds from rights offering and private placement, net of issuance costs | - | 0 | 0 | 0 |
| Proceeds from lines of credit, net of deferred financing costs | 0 | 0 | 14,700 | 71,200 |
| Payments on lines of credit | 10,000 | 5,000 | 25,000 | 86,800 |
| Proceeds from other debt obligations, net of deferred financing costs | - | 500 | 0 | 20,800 |
| Principal payments for and repurchases of other debt obligations | 3,000 | 11,400 | 1,100 | 36,200 |
| Deferred financing costs paid to third parties | - | 500 | - | - |
| Payments to non-controlling interests related to former sale of equity method investment | - | 0 | - | - |
| Dividend payments | 400 | 700 | 400 | 1,100 |
| Other financing activities | -100 | 0 | -100 | -100 |
| Cash (used in) provided by financing activities | -13,500 | -17,100 | -11,900 | -32,200 |
| Effects of exchange rate changes on cash, cash equivalents and restricted cash | 100 | 100 | -300 | 800 |
| Net increase (decrease) in cash and cash equivalents, including restricted cash | 22,500 | 76,600 | 2,100 | -15,300 |
| Cash, cash equivalents and restricted cash, beginning of year | - | 36,100 | 49,300 | - |
| Cash, cash equivalents and restricted cash, beginning of period | 112,700 | - | - | - |
| Cash, cash equivalents and restricted cash, end of year | - | 112,700 | 36,100 | - |
| Cash, cash equivalents and restricted cash, end of period | 135,200 | - | - | - |
INNOVATE Corp. (VATE)
INNOVATE Corp. (VATE)